ID CP51_CANAL Reviewed; 528 AA. AC P10613; Q5A524; Q92208; DT 01-JUL-1989, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1995, sequence version 2. DT 16-JUN-2009, entry version 74. DE RecName: Full=Lanosterol 14-alpha demethylase; DE EC=1.14.13.70; DE AltName: Full=Cytochrome P450 51; DE AltName: Full=CYPLI; DE AltName: Full=P450-LIA1; DE AltName: Full=Sterol 14-alpha demethylase; DE AltName: Full=P450-14DM; GN Name=ERG11; Synonyms=CYP51, ERG16; ORFNames=CaO19.922; OS Candida albicans (Yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; OC Saccharomycetes; Saccharomycetales; mitosporic Saccharomycetales; OC Candida. OX NCBI_TaxID=5476; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=SC5314; RX MEDLINE=89128456; PubMed=2644625; DOI=10.1093/nar/17.2.804; RA Lai M.H., Kirsch D.R.; RT "Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14 alpha- RT demethylase) from Candida albicans."; RL Nucleic Acids Res. 17:804-804(1989). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=CA100, CA11, CA36, and CA95; RA Orru G., Ciusa M.L., Pilia F., Taccori F., Cosentino S., Pisano M.B., RA Meloni M., Fadda M.E.; RT "ERG11 mutations in oral strains of Candida albicans isolated in RT Sardinia."; RL Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=SC5314; RX PubMed=15123810; DOI=10.1073/pnas.0401648101; RA Jones T., Federspiel N.A., Chibana H., Dungan J., Kalman S., RA Magee B.B., Newport G., Thorstenson Y.R., Agabian N., Magee P.T., RA Davis R.W., Scherer S.; RT "The diploid genome sequence of Candida albicans."; RL Proc. Natl. Acad. Sci. U.S.A. 101:7329-7334(2004). RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-48 AND 467-528, AND VARIANT RP LYS-467. RC STRAIN=SS; RX MEDLINE=97354377; PubMed=9210671; RA White T.C.; RT "The presence of an R467K amino acid substitution and loss of allelic RT variation correlate with an azole-resistant lanosterol 14-alpha RT demethylase in Candida albicans."; RL Antimicrob. Agents Chemother. 41:1488-1494(1997). RN [5] RP 3D-STRUCTURE MODELING. RX MEDLINE=95118948; PubMed=7819160; DOI=10.1016/0263-7855(94)80086-3; RA Boscott P.E., Grant G.H.; RT "Modeling cytochrome P450 14-alpha demethylase (Candida albicans) from RT P450cam."; RL J. Mol. Graph. 12:185-192(1994). RN [6] RP VARIANTS FLUCONAZOLE-RESISTANT. RX MEDLINE=97372542; PubMed=9228762; DOI=10.1016/S0378-1097(97)00172-9; RA Loffler J., Kelly S.L., Hebart H., Schumacher U., Lass-Florl C., RA Einsele H.; RT "Molecular analysis of cyp51 from fluconazole-resistant Candida RT albicans strains."; RL FEMS Microbiol. Lett. 151:263-268(1997). CC -!- FUNCTION: Catalyzes C14-demethylation of lanosterol which is CC critical for ergosterol biosynthesis. It transforms lanosterol CC into 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol. CC -!- CATALYTIC ACTIVITY: Obtusifoliol + 3 O(2) + 3 NADPH = 4-alpha- CC methyl-5-alpha-ergosta-8,14,24(28)-trien-3-beta-ol + formate + 3 CC NADP(+) + 4 H(2)O. CC -!- COFACTOR: Heme group (By similarity). CC -!- PATHWAY: Steroid biosynthesis; zymosterol biosynthesis; zymosterol CC from lanosterol: step 1/6. CC -!- SUBCELLULAR LOCATION: Membrane (Potential). Membrane; Single-pass CC membrane protein. CC -!- SIMILARITY: Belongs to the cytochrome P450 family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; X13296; CAA31658.1; -; Genomic_DNA. DR EMBL; EU819548; ACF34636.1; -; Genomic_DNA. DR EMBL; EU819551; ACF34639.1; -; Genomic_DNA. DR EMBL; FJ002303; ACH91036.1; -; Genomic_DNA. DR EMBL; FJ403378; ACJ23064.1; -; Genomic_DNA. DR EMBL; AACQ01000063; EAK97774.1; -; Genomic_DNA. DR EMBL; U67192; AAB08099.1; -; Genomic_DNA. DR EMBL; U67193; AAB08100.1; -; Genomic_DNA. DR PIR; S02713; O4CK51. DR RefSeq; XP_716761.1; -. DR GeneID; 3641571; -. DR CGD; CAL0003627; ERG11. DR OMA; P10613; NFVFPNL. DR BRENDA; 1.14.13.70; 1124. DR DrugBank; DB00646; Nystatin. DR GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell. DR GO; GO:0009055; F:electron carrier activity; IEA:InterPro. DR GO; GO:0020037; F:heme binding; IEA:InterPro. DR GO; GO:0008398; F:sterol 14-demethylase activity; IEA:EC. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR GO; GO:0016126; P:sterol biosynthetic process; IEA:UniProtKB-KW. DR InterPro; IPR001128; Cyt_P450. DR InterPro; IPR017973; Cyt_P450_C. DR InterPro; IPR017972; Cyt_P450_CS. DR InterPro; IPR002403; Cyt_P450_E_grp-IV. DR Gene3D; G3DSA:1.10.630.10; Cyt_P450; 1. DR PANTHER; PTHR19383; Cyt_P450; 1. DR Pfam; PF00067; p450; 1. DR PRINTS; PR00465; EP450IV. DR PRINTS; PR00385; P450. DR PROSITE; PS00086; CYTOCHROME_P450; 1. PE 3: Inferred from homology; KW Heme; Iron; Lipid synthesis; Membrane; Metal-binding; Monooxygenase; KW NADP; Oxidoreductase; Steroid biosynthesis; Sterol biosynthesis. FT CHAIN 1 528 Lanosterol 14-alpha demethylase. FT /FTId=PRO_0000052003. FT METAL 470 470 Iron (heme axial ligand) (By similarity). FT VARIANT 105 105 F -> L (in fluconazole-resistant FT isolates). FT VARIANT 266 266 E -> D (in strain: fluconazole-resistant FT isolates). FT VARIANT 287 287 K -> R (in strain: fluconazole-resistant FT isolates). FT VARIANT 450 450 G -> E (in strain: fluconazole-resistant FT isolates). FT VARIANT 464 464 G -> S (in strain: fluconazole-resistant FT isolates). FT VARIANT 467 467 R -> K (in strain: Isolate 13; azole- FT resistant). FT VARIANT 488 488 V -> I (in strain: fluconazole-resistant FT isolates). FT CONFLICT 19 19 V -> D (in Ref. 4; AAB08099). SQ SEQUENCE 528 AA; 60675 MW; 026948CEE4AF1B88 CRC64; MAIVETVIDG INYFLSLSVT QQISILLGVP FVYNLVWQYL YSLRKDRAPL VFYWIPWFGS AASYGQQPYE FFESCRQKYG DVFSFMLLGK IMTVYLGPKG HEFVFNAKLS DVSAEDAYKH LTTPVFGKGV IYDCPNSRLM EQKKFAKFAL TTDSFKRYVP KIREEILNYF VTDESFKLKE KTHGVANVMK TQPEITIFTA SRSLFGDEMR RIFDRSFAQL YSDLDKGFTP INFVFPNLPL PHYWRRDAAQ KKISATYMKE IKSRRERGDI DPNRDLIDSL LIHSTYKDGV KMTDQEIANL LIGILMGGQH TSASTSAWFL LHLGEKPHLQ DVIYQEVVEL LKEKGGDLND LTYEDLQKLP SVNNTIKETL RMHMPLHSIF RKVTNPLRIP ETNYIVPKGH YVLVSPGYAH TSERYFDNPE DFDPTRWDTA AAKANSVSFN SSDEVDYGFG KVSKGVSSPY LPFGGGRHRC IGEQFAYVQL GTILTTFVYN LRWTIDGYKV PDPDYSSMVV LPTEPAEIIW EKRETCMF //